AIMZ Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.33M | Sell |
9,491
-158
| -2% | -$121K | 2.27% | 8 |
|
|
2025
Q4 | $7.45M | Sell |
9,649
-80
| -0.8% | -$54.3K | 2.13% | 9 |
|
|
2025
Q3 | $5.47M | Sell |
9,729
-125
| -1% | -$70.7K | 1.72% | 12 |
|
|
2025
Q2 | $5.17M | Hold |
9,854
| – | – | 1.73% | 16 |
|
|
2025
Q1 | $6.25M | Hold |
9,854
| – | – | 2.18% | 9 |
|
|
2024
Q4 | $7.02M | Sell |
9,854
-55
| -0.6% | -$46.2K | 2.44% | 8 |
|
|
2024
Q3 | $10.4M | Sell |
9,909
-75
| -0.8% | -$83.5K | 3.56% | 4 |
|
|
2024
Q2 | $10.5M | Sell |
9,984
-185
| -2% | -$179K | 3.76% | 5 |
|
|
2024
Q1 | $9.79M | Sell |
10,169
-270
| -3% | -$257K | 3.65% | 5 |
|
|
2023
Q4 | $9.17M | Sell |
10,439
-171
| -2% | -$141K | 3.71% | 4 |
|
|
2023
Q3 | $8.73M | Sell |
10,610
-64
| -0.6% | -$50.3K | 3.88% | 4 |
|
|
2023
Q2 | $7.67M | Sell |
10,674
-20
| -0.2% | -$15.4K | 3.3% | 5 |
|
|
2023
Q1 | $8.79M | Sell |
10,694
-145
| -1% | -$109K | 3.94% | 3 |
|
|
2022
Q4 | $7.82M | Sell |
10,839
-225
| -2% | -$166K | 3.69% | 3 |
|
|
2022
Q3 | $7.62M | Sell |
11,064
-50
| -0.4% | -$31.5K | 3.86% | 3 |
|
|
2022
Q2 | $6.57M | Sell |
11,114
-50
| -0.4% | -$32.5K | 3.15% | 4 |
|
|
2022
Q1 | $7.8M | Sell |
11,164
-260
| -2% | -$164K | 3.21% | 5 |
|
|
2021
Q4 | $7.21M | Buy |
11,424
+125
| +1% | +$76.9K | 2.81% | 5 |
|
|
2021
Q3 | $6.84M | Sell |
11,299
-140
| -1% | -$86.9K | 3.09% | 6 |
|
|
2021
Q2 | $6.39M | Hold |
11,439
| – | – | 2.86% | 6 |
|
|
2021
Q1 | $5.41M | Buy |
11,439
+50
| +0.4% | +$24.3K | 2.65% | 6 |
|
|
2020
Q4 | $5.5M | Sell |
11,389
-100
| -0.9% | -$54K | 2.88% | 6 |
|
|
2020
Q3 | $6.43M | Sell |
11,489
-170
| -1% | -$103K | 3.85% | 4 |
|
|
2020
Q2 | $7.27M | Sell |
11,659
-55
| -0.5% | -$31.2K | 4.72% | 3 |
|
|
2020
Q1 | $5.72M | Hold |
11,714
| – | – | 4.44% | 3 |
|
|
2019
Q4 | $4.4M | Sell |
11,714
-110
| -0.9% | -$37K | 2.85% | 6 |
|
|
2019
Q3 | $3.28M | Buy |
11,824
+2,294
| +24% | +$679K | 2.26% | 12 |
|
|
2019
Q2 | $2.98M | Hold |
9,530
| – | – | 2.06% | 17 |
|
|
2019
Q1 | $3.91M | Hold |
9,530
| – | – | 2.69% | 6 |
|
|
2018
Q4 | $3.56M | Sell |
9,530
-100
| -1% | -$36.6K | 2.75% | 7 |
|
|
2018
Q3 | $3.89M | Hold |
9,630
| – | – | 2.5% | 8 |
|
|
2018
Q2 | $3.32M | Buy |
9,630
+70
| +0.7% | +$21.9K | 2.35% | 10 |
|
|
2018
Q1 | $3.29M | Buy |
+9,560
| New | +$3.33M | 2.39% | 9 |
|
Other funds holding REGN
VCM
N
AIMZ Investment Advisors's REGN Position: Q1 2026 in Review
AIMZ Investment Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 1.6% in Q1 2026, selling an estimated $121K and leaving 9,491 shares worth $7.33M. The position accounts for 2.27% of the portfolio, ranked #8.
AIMZ Investment Advisors first reported a position in REGN in Q1 2018 and has held it in 33 quarters since. The position peaked at $10.5M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- AIMZ Investment Advisors held 9,491 shares of Regeneron Pharmaceuticals worth $7.33M as of Q1 2026.
- AIMZ Investment Advisors sold 158 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $121K.
- Regeneron Pharmaceuticals made up 2.27% of AIMZ Investment Advisors's portfolio in Q1 2026, its #8 holding.
- AIMZ Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 33 quarters since.
- AIMZ Investment Advisors's Regeneron Pharmaceuticals position peaked at $10.5M in Q2 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on AIMZ Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.